1
|
Canales A, Sastre J, Orduña JM, Spruit CM, Pérez-Castells J, Domínguez G, Bouwman KM, van der Woude R, Cañada FJ, Nycholat CM, Paulson JC, Boons GJ, Jiménez-Barbero J, de Vries RP. Revealing the Specificity of Human H1 Influenza A Viruses to Complex N-Glycans. JACS Au 2023; 3:868-878. [PMID: 37006776 PMCID: PMC10052259 DOI: 10.1021/jacsau.2c00664] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/06/2022] [Revised: 02/03/2023] [Accepted: 02/07/2023] [Indexed: 05/18/2023]
Abstract
Influenza virus infection remains a threat to human health since viral hemagglutinins are constantly drifting, escaping infection and vaccine-induced antibody responses. Viral hemagglutinins from different viruses display variability in glycan recognition. In this context, recent H3N2 viruses have specificity for α2,6 sialylated branched N-glycans with at least three N-acetyllactosamine units (tri-LacNAc). In this work, we combined glycan arrays and tissue binding analyses with nuclear magnetic resonance experiments to characterize the glycan specificity of a family of H1 variants, including the one responsible for the 2009 pandemic outbreak. We also analyzed one engineered H6N1 mutant to understand if the preference for tri-LacNAc motifs could be a general trend in human-type receptor-adapted viruses. In addition, we developed a new NMR approach to perform competition experiments between glycans with similar compositions and different lengths. Our results point out that pandemic H1 viruses differ from previous seasonal H1 viruses by a strict preference for a minimum of di-LacNAc structural motifs.
Collapse
Affiliation(s)
- Angeles Canales
- Department
of Organic Chemistry, Faculty of Chemistry, Universidad Complutense de Madrid, Avd. Complutense s/n, Madrid 28040, Spain
| | - Javier Sastre
- Centro
de Investigaciones Biológicas Margarita Salas, CSIC, C/Ramiro de Maetzu 9, Madrid 28040, Spain
| | - Jose M. Orduña
- Department
of Chemistry and Biochemistry Facultad de Farmacia, Universidad San
Pablo-CEU, CEU Universities Urbanización
Montepríncipe, Boadilla del Monte, Madrid 28660, Spain
| | - Cindy M. Spruit
- Department
of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical
Sciences, Utrecht University, Utrecht 3584 CG, The Netherlands
| | - Javier Pérez-Castells
- Department
of Chemistry and Biochemistry Facultad de Farmacia, Universidad San
Pablo-CEU, CEU Universities Urbanización
Montepríncipe, Boadilla del Monte, Madrid 28660, Spain
| | - Gema Domínguez
- Department
of Chemistry and Biochemistry Facultad de Farmacia, Universidad San
Pablo-CEU, CEU Universities Urbanización
Montepríncipe, Boadilla del Monte, Madrid 28660, Spain
| | - Kim M. Bouwman
- Department
of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical
Sciences, Utrecht University, Utrecht 3584 CG, The Netherlands
| | - Roosmarijn van der Woude
- Department
of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical
Sciences, Utrecht University, Utrecht 3584 CG, The Netherlands
| | - Francisco Javier Cañada
- Centro
de Investigaciones Biológicas Margarita Salas, CSIC, C/Ramiro de Maetzu 9, Madrid 28040, Spain
- Centro
de Investigación Biomédica en Red-Enfermedades Respiratorias
(CIBERES), Instituto de Salud Carlos III, C/ Monforte de Lemos 3-5, Pabellón
11, Madrid 28029, Spain
| | - Corwin M. Nycholat
- Department
of Molecular Medicine, The Scripps Research
Institute, La Jolla, California 92037, United States
| | - James C. Paulson
- Department
of Molecular Medicine, The Scripps Research
Institute, La Jolla, California 92037, United States
| | - Geert-Jan Boons
- Department
of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical
Sciences, Utrecht University, Utrecht 3584 CG, The Netherlands
- Complex
Carbohydrate Research Center, University
of Georgia, 315 Riverbend
Road, Athens, Georgia 30602, United States
| | - Jesús Jiménez-Barbero
- Centro
de Investigación Biomédica en Red-Enfermedades Respiratorias
(CIBERES), Instituto de Salud Carlos III, C/ Monforte de Lemos 3-5, Pabellón
11, Madrid 28029, Spain
- CIC
bioGUNE, Bizkaia Science and Technology
Park, Bilbao 48160, Spain
- IKERBASQUE, Basque Foundation for Science, Bilbao 48009, Spain
- Department
of Organic Chemistry, II Faculty of Science
and Technology University of the Basque Country, EHU-UPV, Leioa 48940, Spain
| | - Robert P. de Vries
- Department
of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical
Sciences, Utrecht University, Utrecht 3584 CG, The Netherlands
| |
Collapse
|